Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Robin

Showing results (131-140 of 298) with videos related to

Pageof 30
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantationFlore Sicre de Fontbrune, Marie Robin, Raphael Porcher, et al.
The Journal of Infectious Diseases|August 1, 2008
Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantationHélène Moins-Teisserenc, Marc Busson, Catherine Scieux, et al.
British Journal of Haematology|June 9, 2007
Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplantsJerome Larghero, Vanderson Rocha, Raphael Porcher, et al.
Blood|September 6, 2012
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantationRégis Peffault de Latour, Rodrigo T Calado, Marc Busson, et al.
Bone Marrow Transplantation|June 2, 2022
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantationAurélien Sutra Del Galy, Adrien Rousseau, Antoine Capes, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2015
Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantationAnne Bergeron, Sylvie Chevret, Karine Chagnon, et al.
Cancer|April 17, 2013
Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO)Christine Chevreau, Axel Le Cesne, Isabelle Ray-Coquard, et al.
Transplantation and Cellular Therapy|August 26, 2023
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter StudyAlexandros Rampotas, Katja Sockel, Fotios Panitsas, et al.
Blood|May 27, 2006
Frequent antibody production against RARalpha in both APL mice and patientsMarie Robin, Juliette Andreu-Gallien, Marie-Helene Schlageter, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Pageof 30

Showing results (131-140 of 298) with videos related to

Sort By:
Pageof 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2007
Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantationFlore Sicre de Fontbrune, Marie Robin, Raphael Porcher, et al.
The Journal of Infectious Diseases|August 1, 2008
Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantationHélène Moins-Teisserenc, Marc Busson, Catherine Scieux, et al.
British Journal of Haematology|June 9, 2007
Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplantsJerome Larghero, Vanderson Rocha, Raphael Porcher, et al.
Blood|September 6, 2012
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantationRégis Peffault de Latour, Rodrigo T Calado, Marc Busson, et al.
Bone Marrow Transplantation|June 2, 2022
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantationAurélien Sutra Del Galy, Adrien Rousseau, Antoine Capes, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2015
Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantationAnne Bergeron, Sylvie Chevret, Karine Chagnon, et al.
Cancer|April 17, 2013
Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO)Christine Chevreau, Axel Le Cesne, Isabelle Ray-Coquard, et al.
Transplantation and Cellular Therapy|August 26, 2023
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter StudyAlexandros Rampotas, Katja Sockel, Fotios Panitsas, et al.
Blood|May 27, 2006
Frequent antibody production against RARalpha in both APL mice and patientsMarie Robin, Juliette Andreu-Gallien, Marie-Helene Schlageter, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Pageof 30